"We discovered that the formation of these tiny tunnels is driven exclusively by a Zika protein called NS1," first author ... Currently, there are no vaccines for Zika, nor is any antiviral ...

Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's ...

India may soon mark a major milestone in its fight against dengue with the anticipated rollout of the Japanese-developed vaccine Qdenga. With plans for domestic production underway, the vaccine ...

Mosquito-borne diseases like Malaria, Dengue, and Chikungunya are common in warm areas. Though similar in symptoms, they ...

Since the early 20 th century, the scientific community has faced multiple challenges to develop effective dengue vaccines. This spanned a variety of techniques – from the use of ox bile to ...

Japanese drugmaker Takeda is gearing up to launch its tetravalent dengue vaccine, Qdenga, in India. The vaccine will be ...

Takeda plans to launch its dengue vaccine, Qdenga, in India by next year through a manufacturing partnership with Biological ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration ...

More information: Huaqi Tang et al, Revealing Mechanopathology Induced by Dengue NS1 Using Organ Chips and Single-Cell Force Spectroscopy, ACS Biomaterials Science & Engineering (2025).